AARON DIODATO

DOYLESTOWN, PA NPI 1396705844

Browse related groups: PA Amgen Inc. All categories

General Payments — all program years on this page

$4,950.85

Category: General Payments
Program years: PY2018–2024
Record count: 222
As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,194.20 across 52 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated

The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of payment	Amount	Records
Food and Beverage	$1,194.20	52

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entity	Amount	Records
Amgen Inc.	$122.65	5
Ardelyx, Inc.	$118.72	5
Boehringer Ingelheim Pharmaceuticals, Inc.	$111.66	4
Kyowa Kirin, Inc.	$108.13	4
Retrophin, Inc.	$99.28	4
Novo Nordisk AS	$94.20	4
CALLIDITAS THERAPEUTICS US INC.	$83.83	4
Acerta Pharma LLC	$71.76	4
Bayer HealthCare Pharmaceuticals Inc.	$67.79	3
Daiichi Sankyo Inc.	$54.12	2
Otsuka America Pharmaceutical, Inc.	$53.98	3
Relypsa, Inc.	$48.21	2
NOVARTIS PHARMACEUTICALS CORPORATION	$38.97	2
Otsuka Pharmaceutical Development & Commercialization, Inc.	$35.96	2
Fresenius USA Marketing, Inc.	$24.87	1
Aurinia Pharma U.S., Inc.	$23.59	1
Alexion Pharmaceuticals, Inc.	$18.82	1
AKEBIA THERAPEUTICS INC	$17.66	1

By program year

Program year	Amount	Records
2018	$430.50	19
2019	$363.15	16
2020	$426.87	15
2021	$537.24	31
2022	$1,126.89	50
2023	$872.00	39
2024	$1,194.20	52

Records — PY2024 (52)

Record ID	Paying entity	Amount	Date	Nature of payment	Dispute status	Published	Source
1086115574	Bayer Healthcare Pharmaceuticals Inc.	$22.74	02/29/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1086203885	Bayer Healthcare Pharmaceuticals Inc.	$22.74	01/22/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1086234744	Bayer Healthcare Pharmaceuticals Inc.	$22.31	07/18/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1086934575	Novartis Pharmaceuticals Corporation	$14.56	01/24/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1086934583	Novartis Pharmaceuticals Corporation	$24.41	09/19/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1089416034	Daiichi Sankyo Inc.	$28.85	03/13/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1089416036	Daiichi Sankyo Inc.	$25.27	09/10/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1108574608	Novo Nordisk Inc	$23.44	06/12/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1108576405	Novo Nordisk Inc	$25.39	10/04/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1108576935	Novo Nordisk Inc	$23.49	02/09/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1108578953	Novo Nordisk Inc	$21.88	04/17/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1110532437	AstraZeneca Pharmaceuticals LP	$15.57	06/30/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1110540063	AstraZeneca Pharmaceuticals LP	$19.13	02/28/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1110544239	AstraZeneca Pharmaceuticals LP	$17.93	01/30/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1110549090	AstraZeneca Pharmaceuticals LP	$19.13	01/03/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1110553488	Alexion Pharmaceuticals, Inc.	$18.82	10/09/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1111564329	Amgen Inc.	$22.02	07/09/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1117239823	Amgen Inc.	$21.41	02/12/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1117239825	Amgen Inc.	$19.14	08/06/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1117239827	Amgen Inc.	$26.45	08/26/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1117239829	Amgen Inc.	$33.63	11/25/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1117993138	Boehringer Ingelheim Pharmaceuticals, Inc.	$18.47	10/10/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1117993140	Boehringer Ingelheim Pharmaceuticals, Inc.	$29.87	02/22/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1117993142	Boehringer Ingelheim Pharmaceuticals, Inc.	$30.46	11/26/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1117993144	Boehringer Ingelheim Pharmaceuticals, Inc.	$32.86	05/21/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1118836351	Otsuka Pharmaceutical Development & Commercialization, Inc.	$16.81	05/08/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1118836353	Otsuka Pharmaceutical Development & Commercialization, Inc.	$19.15	11/05/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1118885587	Otsuka America Pharmaceutical, Inc.	$16.62	01/04/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1118885589	Otsuka America Pharmaceutical, Inc.	$15.25	06/03/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1118885591	Otsuka America Pharmaceutical, Inc.	$22.11	08/12/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1124053222	Vifor Pharma, Inc.	$25.74	06/06/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1124055429	Vifor Pharma, Inc.	$22.47	08/19/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1127023754	Kyowa Kirin, Inc.	$27.61	02/16/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1127023756	Kyowa Kirin, Inc.	$28.42	02/01/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1127023758	Kyowa Kirin, Inc.	$23.73	07/30/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1127023760	Kyowa Kirin, Inc.	$28.37	10/30/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1141508153	CALLIDITAS THERAPEUTICS US INC.	$17.41	01/17/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1141515845	CALLIDITAS THERAPEUTICS US INC.	$19.95	05/24/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1141519227	CALLIDITAS THERAPEUTICS US INC.	$24.24	07/25/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1141526798	CALLIDITAS THERAPEUTICS US INC.	$22.23	11/08/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1145826994	AKEBIA THERAPEUTICS INC	$17.66	05/24/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1146678395	Ardelyx, Inc.	$20.73	02/01/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1146678397	Ardelyx, Inc.	$27.02	03/14/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1146678399	Ardelyx, Inc.	$20.18	05/17/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1146678401	Ardelyx, Inc.	$26.50	08/21/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1146678403	Ardelyx, Inc.	$24.29	11/21/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1149918192	Travere Therapeutics, Inc.	$20.49	04/09/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1149918196	Travere Therapeutics, Inc.	$24.64	12/06/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1149918201	Travere Therapeutics, Inc.	$26.66	06/11/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1149918204	Travere Therapeutics, Inc.	$27.49	09/18/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1150679255	Aurinia Pharma U.S., Inc.	$23.59	01/25/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1154199916	Fresenius USA Marketing, Inc.	$24.87	10/22/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS

Provenance & corrections

Dataset: CMS Open Payments — General Payments
Source: CMS Open Payments dataset (bulk file)
Publisher of source data: Centers for Medicare & Medicaid Services
Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.